{"name":"Elanco Animal Health","slug":"elanco","ticker":"ELAN","exchange":"NYSE","domain":"elanco.com","description":"Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.","hq":"Greenfield, IN, USA","founded":0,"employees":"9400","ceo":"Jeffrey N. Simmons","sector":"Animal Health","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":21.93,"stockChange":0.13,"stockChangePercent":0.6,"marketCap":"$11.0B","metrics":{"revenue":4893000192,"revenueGrowth":14.9,"grossMargin":55.1,"rdSpend":368000000,"netIncome":-232000000,"cash":428000000,"dividendYield":0,"peRatio":18.1,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"earnings","headline":"Elanco Animal Health Reports Fourth-Quarter and Full-Year 2023 Results","summary":"Elanco reported fourth-quarter net sales of $1.43 billion, up 2% from the prior year, and full-year net sales of $5.43 billion, up 4% from the prior year.","drugName":"","sentiment":"neutral"},{"date":"2023-11-01","type":"deal","headline":"Elanco Animal Health Announces Agreement to Acquire Bioveta","summary":"Elanco announced an agreement to acquire Bioveta, a leading animal health company in Europe, for approximately $1.05 billion.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"regulatory","headline":"FDA Approves Elanco's XENEX UV Light Disinfection System for Use in Veterinary Settings","summary":"The FDA approved Elanco's XENEX UV light disinfection system for use in veterinary settings, expanding its use beyond human healthcare settings.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE1tTkJ5bGhnLWw3OS1kMGNpeWtsUGFwMFRwMkRSQ1dhejE3U2x4MzZrLUozQlpnV3RycjBLN0M1Qy1JQTNCb3owcFVEa194NkxMNUJZbFp4UUNZLVhWQWfSAWNBVV95cUxPVUxzeVZUQ25IR3FWZGYxWUlCY2tidHlLZU9Ia1pWUi05Ml94OWczd1A0aWx4dDZLZzAtblpfQnJDWjJOQ0dULUUycXY0N3FxSG9ZZDgwdWRSZVRSQXllSTJISWs?oc=5","date":"2026-03-27","type":"pipeline","source":"Bitget","summary":"Elanco Animal Health Drops More Than 5% – What’s Behind the Abrupt Decline? - Bitget","headline":"Elanco Animal Health Drops More Than 5% – What’s Behind the Abrupt Decline?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE5ucVY2d3RIbFJzd3ctczdyZ3k3M0E3Q21RTTBTcm9FOW12YVBhREVHWXU0UDREcU96UExIM3E0b3piajEtOEJQLUJmN09aaTg0TnczZHZiRTBLaXc?oc=5","date":"2026-03-23","type":"earnings","source":"Intellectia AI","summary":"ELAN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI","headline":"ELAN Financials: Revenue Breakdown, Margins & Competitor Comparison","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-20","type":"pipeline","source":"simplywall.st","summary":"Assessing Elanco Animal Health’s Valuation After Its Strong 1 Year Total Return - simplywall.st","headline":"Assessing Elanco Animal Health’s Valuation After Its Strong 1 Year Total Return","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-08","type":"pipeline","source":"simplywall.st","summary":"Is It Time To Reassess Elanco (ELAN) After A 110% One-Year Share Price Surge - simplywall.st","headline":"Is It Time To Reassess Elanco (ELAN) After A 110% One-Year Share Price Surge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxORzdaTVZhUmtjRC1ZbWFSZkRURTVlbHkyWDRrd1hzSGNHTG5USlg3Q3VkN0l5TVl6VmxhckNnREVVaGgtVWtmQkVyaDBiSWh2YUNobXBSRTdERVg3QjVlTC1KX1dLUExyaEt1TFU5dHBZMHRLNmE4Y0F3czFMVTFIN2M0ZXd4U1JReE5pMEhJNko2MmxCTVRCaUdSYldEMGVQRElfcGdB?oc=5","date":"2026-02-24","type":"earnings","source":"StockStory","summary":"Elanco (NYSE:ELAN) Surprises With Q4 CY2025 Sales - StockStory","headline":"Elanco (NYSE:ELAN) Surprises With Q4 CY2025 Sales","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNS2VCT1QxZDU5cDg3TmJtdUkzS2gtN2VqbHUwdHIzbkF6QXBIQUYtb2FiU2M5OEdRMm94WGFHSG9OeEE4eU5QSkhJNzBOODcwVnVjVDlEbklGby04RV9neGFxZWt5ZGRJNjVfR1l0T242UEtuOHQza21Wdm95Y3lkUmpCd2M1aGFZVVhuSnNsZVBuV0J1VHBiSkhuS19OaWdfaE9mZ3hBWDI4OFI2a3R0ZWdHVy1vOWtKOFl1VDFR?oc=5","date":"2026-01-09","type":"pipeline","source":"Seeking Alpha","summary":"Elanco Animal Health: Innovation-Led Growth Model Plus Credible Deleveraging Path (ELAN) - Seeking Alpha","headline":"Elanco Animal Health: Innovation-Led Growth Model Plus Credible Deleveraging Path (ELAN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPYzdYZlpxb1N3Sm5mN3BaRkpYZDVNVVhlTFhadjBndlRTSkVyMl9ZeGZpTklHbXFkYnMtTVhocXl1RDZFTHJtRzRocjFTenhfN0JXN2xIS0YtWEt0ejI0TnphTkdLczgzeHVJSWNHVkh0SlJ1TEwycUwtQmVWUVQ1dFlCTjBlWnhtbXV2N2YyMTd5VW12SWVtSUhOSGY?oc=5","date":"2025-11-05","type":"earnings","source":"StockStory","summary":"Elanco (NYSE:ELAN) Surprises With Q3 Sales - StockStory","headline":"Elanco (NYSE:ELAN) Surprises With Q3 Sales","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOajIwQVd0cy1rT2FVTFdPSWk4cGlsU0ttZlVtSm5VQUJVYnJybWd5dWR3WENJcTEzOWdrc05QNS05UGhJZk5velE3UEMwVnBDdmpHRUxpckFPQU5fUkNFVVZBejBMU0Y4dHVDbXpuczNvYklhc0JzZXM0WFlOWUphUlppYw?oc=5","date":"2025-10-22","type":"pipeline","source":"Yahoo Finance","summary":"Is Elanco Animal Health (ELAN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance","headline":"Is Elanco Animal Health (ELAN) Stock Outpacing Its Medical Peers This Year?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOclFDNDdjREVyaVFMbVd1ek1TWHZCeC1GcTBodnJVeUtpcHJlOThscERLX25yei12WEhzNHUwNHFSYUU5al9uNHJjbnN0QzVSam43Mjd5ZXVQU2xsN2ktRVZRVGRtcXBjTTl1SEVTb2lNQWJOSGJBZnBPZFotcDgwazhNazJ0NTBGang4Sw?oc=5","date":"2025-09-23","type":"earnings","source":"Yahoo Finance","summary":"Elanco Animal Health Incorporated (ELAN) Joins S&P MidCap 400 Following Strong Q2 Growth and Product Ramp-Up - Yahoo Finance","headline":"Elanco Animal Health Incorporated (ELAN) Joins S&P MidCap 400 Following Strong Q2 Growth and Product Ramp-Up","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxORmRMZmtud29CcU9IclljcFpRVjJlQzlkTElBSmo3a0U1RlBMVXRFaFk2bnJ5Z0UtYl9MeXhGMjhZN2tSRVBzNVhINkk1aHRuN0hCdkZoX2dQSUhaRU9lOTBOb3hnTDIzdFZXaDE0NUFwR19UWFltX0F0T1NvSW1yOWVVWW1hb3N4NWY3cHQ4MHlmOFZBbmlLblJYMmRwVVJ3SjdCVllPM245YVgzUlE?oc=5","date":"2025-07-09","type":"pipeline","source":"Reuters","summary":"Elanco's dog flu vaccine gets USDA nod - Reuters","headline":"Elanco's dog flu vaccine gets USDA nod","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxOd2ZkOGhHdTBuS2o2NjhWclVQZWkwM21tbWV4bHNQQ0hVSGFrMS1XMDZ1Tk1POW9iWFJxVFBwSnRWbHhFSnFBY0ZOR2NkdF8xby1UUVRSRGxJZ2lqMFFJNG9zb3BzbDhNc2lHbmlZV2NLd0V5cWhpdzZiTVlTWDdyRDZ2TUlsUHl6aElYOWlqYlJPWHlJQUVfUE5aMzFrOXkxSWVfZ004VFNEN3V4SVBmb3RVZnVSRnVuV2JRcTNTVGw4a292WVpYeElxOWdvSXlVWVR0VHFPRFhFdmtfaFJqN3RtejJJQ1pkcU5sREdXak9MbGpzREE5M01R?oc=5","date":"2025-05-05","type":"pipeline","source":"PR Newswire","summary":"Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown - PR Newswire","headline":"Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9PWU9Qd0N6bFNva1hkVzdYOUszRXVNb0ppdlV5SGl0anhPUmU0N2NzMGMyQjVBUlR2R2V3ekhqMFpuakJHTnlyOG1ldDYtRUFSdlZJ?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"ELAN Stock Price, News & Analysis | Elanco Animal Health - Stock Titan","headline":"ELAN Stock Price, News & Analysis | Elanco Animal Health","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":["Zoetis Inc. (ZTS)","Merck & Co., Inc. (MRK)","Bayer AG (BAYRY)"],"therapeuticFocus":["Companion Animal Health","Food Animal Health","Livestock Health"],"financials":{"source":"sec_edgar+yahoo","revenue":4715000000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":4715000000,"period":"2025-12-31"},{"value":4439000000,"period":"2024-12-31"},{"value":4439000000,"period":"2024-12-31"},{"value":4417000000,"period":"2023-12-31"},{"value":4417000000,"period":"2023-12-31"}],"grossProfit":2593000000,"grossProfitHistory":[{"period":"2025-12-31","value":2593000000},{"period":"2024-12-31","value":2436000000},{"period":"2023-12-31","value":2486000000},{"period":"2022-12-31","value":2498000000}],"rdSpend":368000000,"rdSpendHistory":[{"period":"2025-12-31","value":368000000},{"period":"2024-12-31","value":344000000},{"period":"2023-12-31","value":327000000},{"period":"2022-12-31","value":321000000}],"sgaSpend":1430000000,"operatingIncome":252000000,"operatingIncomeHistory":[{"period":"2025-12-31","value":252000000},{"period":"2024-12-31","value":251000000},{"period":"2023-12-31","value":326000000},{"period":"2022-12-31","value":384000000}],"netIncome":-232000000,"netIncomeHistory":[{"period":"2025-12-31","value":-232000000},{"period":"2024-12-31","value":338000000},{"period":"2023-12-31","value":-1231000000},{"period":"2022-12-31","value":-78000000}],"eps":-0.47,"epsHistory":[{"period":"2025-12-31","value":-0.47},{"period":"2024-12-31","value":0.68},{"period":"2023-12-31","value":-2.5},{"period":"2022-12-31","value":-0.15}],"cash":545000000,"cashHistory":[{"period":"2025-12-31","value":545000000},{"period":"2024-12-31","value":468000000},{"period":"2023-12-31","value":352000000},{"period":"2022-12-31","value":345000000}],"totalAssets":13358000000,"totalLiabilities":6811000000,"totalDebt":4017000000,"equity":6547000000,"operatingCashflow":560000000,"operatingCashflowHistory":[{"period":"2025-12-31","value":560000000},{"period":"2024-12-31","value":541000000},{"period":"2023-12-31","value":271000000},{"period":"2022-12-31","value":452000000}],"capex":-276000000,"capexHistory":[{"period":"2025-12-31","value":-276000000},{"period":"2024-12-31","value":-147000000},{"period":"2023-12-31","value":-140000000},{"period":"2022-12-31","value":-184000000}],"freeCashflow":284000000,"dividendsPaid":null,"buybacks":null,"employees":9400,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":381000000,"ebit":144000000,"ebitda":316000000,"period":"2026-03-31","revenue":1371000000,"epsBasic":0.11,"netIncome":57000000,"rdExpense":97000000,"epsDiluted":0.11,"grossProfit":785000000,"operatingIncome":169000000},{"sga":338000000,"ebit":-179000000,"ebitda":-5000000,"period":"2025-12-31","revenue":1144000000,"epsBasic":-0.56,"netIncome":-276000000,"rdExpense":93000000,"epsDiluted":-0.56,"grossProfit":589000000,"operatingIncome":19000000},{"sga":351000000,"ebit":2000000,"ebitda":178000000,"period":"2025-09-30","revenue":1137000000,"epsBasic":-0.07,"netIncome":-34000000,"rdExpense":89000000,"epsDiluted":-0.07,"grossProfit":607000000,"operatingIncome":27000000},{"sga":400000000,"ebit":73000000,"ebitda":242000000,"period":"2025-06-30","revenue":1241000000,"epsBasic":0.02,"netIncome":11000000,"rdExpense":92000000,"epsDiluted":0.02,"grossProfit":713000000,"operatingIncome":85000000},{"sga":341000000,"ebit":100000000,"ebitda":261000000,"period":"2025-03-31","revenue":1193000000,"epsBasic":0.14,"netIncome":67000000,"rdExpense":94000000,"epsDiluted":0.13,"grossProfit":684000000,"operatingIncome":121000000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":21.93,"previousClose":21.8,"fiftyTwoWeekHigh":27.72,"fiftyTwoWeekLow":12.4,"fiftyTwoWeekRange":"12.4 - 27.72","fiftyDayAverage":23.4,"twoHundredDayAverage":21.82,"beta":1.69,"enterpriseValue":14760000512,"forwardPE":18.1,"priceToBook":1.69,"priceToSales":2.24,"enterpriseToRevenue":3.02,"enterpriseToEbitda":15.22,"pegRatio":4.04,"ebitda":970000000,"ebitdaMargin":19.8,"freeCashflow":692124992,"operatingCashflow":577000000,"totalDebt":4300000256,"debtToEquity":66.2,"currentRatio":2.16,"returnOnAssets":1.5,"returnOnEquity":-3.8,"analystRating":"1.4 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":14,"targetMeanPrice":29.86,"targetHighPrice":32,"targetLowPrice":24,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":1.2,"institutionHeldPercent":111.8,"sharesOutstanding":499449583,"floatShares":494939553,"sharesShort":24342462,"shortRatio":5.62,"shortPercentOfFloat":4.9,"epsTrailing":-0.5,"epsForward":1.21,"revenuePerShare":9.84,"bookValue":13.02,"officers":[{"age":58,"name":"Mr. Jeffrey N. Simmons","title":"President, CEO & Director"},{"age":49,"name":"Mr. Robert M. VanHimbergen","title":"Executive VP & CFO"},{"age":53,"name":"Dr. Ramiro Martin Cabral","title":"Executive VP & President of Elanco International"},{"age":62,"name":"Dr. Ellen  de Brabander Ph.D.","title":"Executive Vice President of Research, Development & Regulatory Affairs"},{"age":51,"name":"Mr. Timothy J. Bettington","title":"Executive Vice President of Center of Strategic Growth"},{"age":55,"name":"Mr. James M. Meer","title":"Senior VP & Chief Accounting Officer"},{"age":58,"name":"Mr. David S. Kinard","title":"Executive Vice President of Human Resources, Corporate Communications & Administration"},{"age":null,"name":"Ms. Tiffany Ann Kanaga","title":"VP of Investor Relations & ESG"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.elanco.com","phone":"877 352 6261"}}